Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Ketorolac Trometamol
Therapeutic Area : Neurology
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Ketorolac Tromethamine is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Pain, Postoperative.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
April 12, 2022
Lead Product(s) : Ketorolac Trometamol
Therapeutic Area : Neurology
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Phenobarbital Sodium
Therapeutic Area : Neurology
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy and Safety of Intravenous Phenobarbital in Neonatal Seizures
Details : Phenobarbital Sodium is a Controlled Substance drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Epilepsy, Benign Neonatal.
Product Name : Undisclosed
Product Type : Controlled Substance
Upfront Cash : Inapplicable
March 25, 2020
Lead Product(s) : Phenobarbital Sodium
Therapeutic Area : Neurology
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Hydrocodone Bitartrate
Therapeutic Area : Neurology
Study Phase : Phase IV
Sponsor : Medtronic plc | International Clinical Research Institute
Deal Size : Inapplicable
Deal Type : Inapplicable
Pharmacokinetic Study of Hydrocodone/APAP in Chronic Pain Patients
Details : Hydrocodone is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Chronic Pain.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
January 25, 2012
Lead Product(s) : Hydrocodone Bitartrate
Therapeutic Area : Neurology
Highest Development Status : Phase IV
Sponsor : Medtronic plc | International Clinical Research Institute
Deal Size : Inapplicable
Deal Type : Inapplicable